Style | Citing Format |
---|---|
MLA | Dastjerdi MN, et al.. "The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line." Research in Pharmaceutical Sciences, vol. 11, no. 4, 2016, pp. 303-310. |
APA | Dastjerdi MN, Rarani MZ, Valiani A, Mahmoudieh M (2016). The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line. Research in Pharmaceutical Sciences, 11(4), 303-310. |
Chicago | Dastjerdi MN, Rarani MZ, Valiani A, Mahmoudieh M. "The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line." Research in Pharmaceutical Sciences 11, no. 4 (2016): 303-310. |
Harvard | Dastjerdi MN et al. (2016) 'The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line', Research in Pharmaceutical Sciences, 11(4), pp. 303-310. |
Vancouver | Dastjerdi MN, Rarani MZ, Valiani A, Mahmoudieh M. The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line. Research in Pharmaceutical Sciences. 2016;11(4):303-310. |
BibTex | @article{ author = {Dastjerdi MN and Rarani MZ and Valiani A and Mahmoudieh M}, title = {The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line}, journal = {Research in Pharmaceutical Sciences}, volume = {11}, number = {4}, pages = {303-310}, year = {2016} } |
RIS | TY - JOUR AU - Dastjerdi MN AU - Rarani MZ AU - Valiani A AU - Mahmoudieh M TI - The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line JO - Research in Pharmaceutical Sciences VL - 11 IS - 4 SP - 303 EP - 310 PY - 2016 ER - |